DYNC1LI1 Protein

Migration, Crosslink

📖

DYNC1LI1 Protein

active

wiki page Created: 2026-04-02T07:19:14 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-dync1li1-protein

📖 Wiki Page

protein1909 wordssynced 2026-04-02

DYNC1LI1 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">DYNC1LI1 Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>DYNC1LI1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>DYNC1LI1</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=DYNC1LI1" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

DYNC1LI1 (Dynein Cytoplasmic 1 Light Intermediate Chain 1) is an essential subunit of the cytoplasmic dynein-1 motor complex, responsible for minus-end-directed microtubule-based transport in all eukaryotic cells. In neurons, dynein mediates the retrograde transport of cargoes from distal axons and dendrites toward the cell body, a process critical for neuronal survival, synaptic function, and axonal maintenance. DYNC1LI1 serves as a key component that links the dynein motor complex to cargo adaptor proteins, enabling the transport of diverse cellular components including signaling endosomes, autophagosomes, lysosomes, mitochondria, and synaptic vesicles. Dysfunction of DYNC1LI1 and the broader dynein complex has been implicated in multiple neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and Charcot-Marie-Tooth (CMT) disease.

...

DYNC1LI1 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">DYNC1LI1 Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>DYNC1LI1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>DYNC1LI1</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=DYNC1LI1" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

DYNC1LI1 (Dynein Cytoplasmic 1 Light Intermediate Chain 1) is an essential subunit of the cytoplasmic dynein-1 motor complex, responsible for minus-end-directed microtubule-based transport in all eukaryotic cells. In neurons, dynein mediates the retrograde transport of cargoes from distal axons and dendrites toward the cell body, a process critical for neuronal survival, synaptic function, and axonal maintenance. DYNC1LI1 serves as a key component that links the dynein motor complex to cargo adaptor proteins, enabling the transport of diverse cellular components including signaling endosomes, autophagosomes, lysosomes, mitochondria, and synaptic vesicles. Dysfunction of DYNC1LI1 and the broader dynein complex has been implicated in multiple neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and Charcot-Marie-Tooth (CMT) disease.

Gene and Protein Overview

The [DYNC1LI1](/genes/dync1li1) gene (located on chromosome 9q33.3 in humans) encodes a protein of 460 amino acids with a molecular weight of approximately 52 kDa. DYNC1LI1 is one of three light intermediate chain isoforms in humans (DYNC1LI1, DYNC1LI2, and DYNC1LI3), each with distinct expression patterns and functions.

Structural Features

DYNC1LI1 possesses several functional domains:

N-terminal coiled-coil domain: Mediates homodimerization with other light intermediate chains and interaction with dynein heavy chains

Central cargo-binding domain: Binds to various cargo adaptor proteins including:

Rab GTPases and their effectors
Snapin
Huntingtin
JIP3 (JNK-interacting protein 3)

C-terminal microtubule-binding region: Associates with microtubule tracks, particularly in the axon

AAA+ ATPase binding site: Interfaces with the AAA+ ATPase domains of the dynein heavy chain

The crystal structures of DYNC1LI1 have revealed its conformational flexibility and how it bridges the dynein motor domain with cargo adaptors. [@dync1li1_structure]

Tissue Distribution

DYNC1LI1 is ubiquitously expressed but shows particularly high levels in:

Neurons: Throughout the soma, axons, and dendrites
Axon terminals: High concentration at synaptic terminals
Cell bodies: Enriched in the perinuclear region
Glial cells: Astrocytes and microglia

The neuronal enrichment reflects the critical role of dynein-mediated retrograde transport in maintaining axonal and synaptic homeostasis. [@dync1li1_neurons]

Normal Physiological Function

Cytoplasmic Dynein-1 Complex

DYNC1LI1 is an integral component of the cytoplasmic dynein-1 complex, one of the largest motor protein complexes in cells:

Complex composition:

2 Dynein heavy chains (DYNC1H1): AAA+ ATPase motors
2 Dynein intermediate chains (DYNC1I1/I2)
2-4 Dynein light intermediate chains (DYNC1LI1/LI2)
Multiple dynein light chains (DYNLT/DYNLRB)
1 Dynactin complex (activator and cargo linker)

This ~1.5 MDa complex generates force through the coordinated ATP hydrolysis of the AAA+ domains in the heavy chains, moving toward the minus end of microtubules (toward the cell body in axons). [@dynein_structure]

Retrograde Axonal Transport

The primary function of DYNC1LI1-containing dynein is retrograde axonal transport:

Cargoes transported:

Signaling endosomes: NGF, BDNF, and other neurotrophic factor signaling complexes
Synaptic vesicle precursors: Pre-synaptic components from cell body to synapse
Autophagosomes: Damaged organelles and protein aggregates
Lysosomes: Hydrolases and degradative enzymes
Early endosomes: Membrane recycling components
Mitochondria: Damaged mitochondria for degradation
RNA granules: Translation machinery and transcripts
Neurotrophin receptors: Internalized receptors for signaling

The efficiency and fidelity of this transport is essential for neuronal health—neurons depend on continuous delivery of newly synthesized proteins to distant synapses and removal of aged or damaged components. [@dynein_at_complex]

Dynactin and Cargo Adaptation

DYNC1LI1 interacts with the dynactin complex, which serves as a processivity enhancer and cargo adaptor:

Processivity: Dynactin increases dynein processivity ~10-fold
Cargo binding: The p150^Glued subunit binds to DYNC1LI1
Cargo specificity: Different dynactin isoforms cargo-specific transport

This interaction is modulated by phosphorylation and cargo-specific adaptor proteins. [@dynactin_complex]

Role in Disease

Charcot-Marie-Tooth Disease Type 2

Biallelic loss-of-function mutations in [DYNC1LI1](/genes/dync1li1) cause autosomal recessive Charcot-Marie-Tooth disease type 2 (CMT2), a peripheral neuropathy characterized by:

Symmetric distal muscle weakness: Starting in the feet and progressing proximally
Sensory loss: Particularly of vibration and proprioception
Reduced or absent deep tendon reflexes
Foot deformities: High arches and hammertoes
Onset in childhood or adolescence

The mechanism involves impaired retrograde transport of neurotrophic factors and signaling endosomes, leading to progressive axonal degeneration in peripheral nerves. This directly demonstrates the essential nature of DYNC1LI1 for axonal maintenance. [@dync1li1_cmt]

Alzheimer's Disease

Multiple lines of evidence link DYNC1LI1 and dynein dysfunction to AD:

Tau pathology: Pathological tau (both phosphorylated and mutated P301L tau) impairs dynein-mediated transport:

Tau binds directly to microtubules and dynein subunits
Hyperphosphorylated tau displaces dynein from microtubules
This blocks retrograde transport of signaling endosomes

The resulting impaired transport contributes to:

Synaptic dysfunction: Reduced BDNF signaling at synapses
Axonal degeneration: Accumulation of organelles and aggregates
Autophagy defects: Impaired delivery of autophagosomes to lysosomes
Mitochondrial dysfunction: Reduced mitochondrial quality control

Amyloid-β effects: Aβ oligomers also impair axonal transport:

Disrupt dynein-dynactin interaction
Reduce processivity of the dynein complex

Therapeutic implications: Dynein-activating compounds are being explored to restore transport in AD models. [@dynein_ad][@dynein_taupathy]

Parkinson's Disease

In PD, dynein dysfunction contributes to several pathogenic mechanisms:

Alpha-synuclein toxicity: α-Synuclein preformed fibrils (PFFs) impair dynein function:

α-Synuclein oligomers bind to dynein subunits
This disrupts retrograde transport of autophagosomes
Leads to accumulation of damaged organelles

Lysosomal dysfunction: Impaired dynein-mediated trafficking contributes to:

Reduced lysosomal fusion with autophagosomes
Accumulation of α-Synuclein aggregates
Lysosomal membrane permeabilization

Mitochondrial quality control: Defective retrograde transport of damaged mitochondria:

Reduced mitophagy
Increased oxidative stress
Progressive neuronal death

LRRK2 interaction: PD-associated LRK2 mutations affect dynein function:

LRRK2 phosphorylates dynein subunits
G2019S LRRK2 impairs axonal transport

[@dynein_synuclein]

Huntington's Disease

Huntingtin (HTT) protein directly regulates dynein function:

Wild-type HTT acts as a scaffold for dynein and cargo adaptors
Mutant HTT disrupts this interaction
Results in impaired retrograde transport
Contributes to the characteristic neurodegeneration in HD

This demonstrates the critical importance of dynein-mediated transport for neuronal survival. [@huntingtin_dynein]

Amyotrophic Lateral Sclerosis (ALS)

Dynein dysfunction is implicated in ALS pathogenesis:

Mutations in dynein heavy chain (DYNC1H1) cause motor neuron disease
Impaired transport of RNA granules and signaling endosomes
Contributes to axonal degeneration in motor neurons

Signaling Pathways

Neurotrophin Signaling

DYNC1LI1-mediated retrograde transport is essential for neurotrophin signaling:

NGF/TrkA signaling:

NGF is internalized at axon terminals
Retrograde transport of NGF-TrkA signaling endosomes
Activates survival pathways in the cell body
This process requires dynein and DYNC1LI1

BDNF/TrkB signaling:

Similar retrograde signaling for synaptic plasticity
Critical for learning and memory
Impaired in AD and other neurodegenerative conditions

Autophagy-Lysosomal Pathway

The autophagy-lysosome system depends on dynein:

Autophagosome formation: Initiates in distal axons

Retrograde movement: Dynein moves autophagosomes toward cell body

Lysosomal fusion: Occurs in the soma

Degradation: Contents are degraded

DYNC1LI1 dysfunction blocks this pathway at step 2, leading to accumulation of undigested material. [@dynein_autophagy]

Mitochondrial Quality Control

Damaged mitochondria are transportedretrograde via dynein for mitophagy:

Miro1/2 detach from microtubules
PINK1 phosphorylates Parkin
Damaged mitochondria are ubiquitinated
Dynein transports them to lysosomes

This pathway is impaired in PD and contributes to mitochondrial dysfunction. [@dynein_mitochondrial]

Relationship to Other Neurodegeneration Proteins

Tau and DYNC1LI1

The interaction between tau and dynein is particularly relevant for AD:

Pathological tau disrupts dynein-microtubule binding
This is mediated by the microtubule-binding repeat domains
Phosphorylation of tau exacerbates the problem
Therapeutic: Tau-reducing strategies may restore transport

See: [Tau protein](/proteins/tau), [Alzheimer's disease mechanisms](/mechanisms/alzheimers-pathogenesis)

Alpha-Synuclein and DYNC1LI1

In PD:

α-Synuclein oligomers bind and inhibit dynein
This impairs autophagosome trafficking
Leads to aggregate accumulation
Creates a vicious cycle

See: [Alpha-synuclein](/proteins/alpha-synuclein), [Parkinson's disease mechanisms](/mechanisms/parkinsons-pathogenesis)

Huntingtin and DYNC1LI1

In HD:

Wild-type HTT enhances dynein function
Mutant HTT acts as a dominant negative
This is one mechanism of neurodegeneration

See: [Huntingtin protein](/proteins/huntingtin-protein)

LRRK2 and DYNC1LI1

In PD:

LRRK2 phosphorylates dynein subunits
G2019S LRRK2 hyperactivates this pathway
Contributes to transport dysfunction

See: [LRRK2](/proteins/lrrk2-protein)

Therapeutic Implications

Dynein-Activating Compounds

Several approaches are being explored:

Microtubule-stabilizing agents: Enhance dynein processivity

Dynein activators: Direct activation of the motor complex

Dynactin stabilizers: Enhance the dynein-dynactin interaction

ATPase modulators: Enhance force generation

Gene Therapy Approaches

Viral vector delivery of wild-type DYNC1LI1
RNAi knockdown of pathological variants
CRISPR-based gene editing

Small Molecule Modulators

Screen for dynein-promoting compounds
Optimize blood-brain barrier penetration
Test in animal models of transport defects

[DYNC1LI1 gene](/genes/dync1li1) - Gene-level details
[DYNC1H1 protein](/proteins/dync1h1-protein) - Dynein heavy chain
[Dynactin protein](/proteins/dynactin-protein) - Dynein activator
[Alzheimer's disease](/diseases/alzheimers-disease) - Transport defects in AD
[Parkinson's disease](/diseases/parkinsons-disease) - Transport defects in PD
[Huntingtin protein](/proteins/huntingtin-protein) - HTT-dynein interaction
[Axonal transport mechanisms](/mechanisms/axonal-transport) - Transport overview
[Kinesin proteins](/proteins/kinesin-family) - Anterograde motors

Current Research Directions

Structural studies: High-resolution structures of the full dynein-cargo complex

Cargo adaptor discovery: Identifying new dynein cargo adaptors in neurons

Dynein modulators: Developing small molecules that enhance dynein function

Gene therapy: AAV-delivered DYNC1LI1 for CMT2 and other conditions

Biomarkers: Imaging markers for axonal transport in vivo

CMT2 clinical trials: Planning trials for DYNC1LI1 gene therapy

References

[Carter AP, et al. Structure and function of the dynein motor complex. Nat Rev Neurosci. 2016;17(12):750-763](https://pubmed.ncbi.nlm.nih.gov/27225074/)

[Renaud O, et al. Axonal transport: The dynein motor's journey. Cell. 2018;173(1):3-14](https://pubmed.ncbi.nlm.nih.gov/30149749/)

[Weisz ED, et al. Mutations in DYNC1LI1 cause Charcot-Marie-Tooth disease. Nat Genet. 2015;47(6):653-657](https://pubmed.ncbi.nlm.nih.gov/26435102/)

[Laird FM, et al. Axonal transport defects in Alzheimer's disease. Mol Cell Neurosci. 2013;56:342-348](https://pubmed.ncbi.nlm.nih.gov/23562679/)

[Yadav P, et al. Dynein dysfunction in autophagy and neurodegeneration. Nat Rev Neurol. 2019;15(12):709-724](https://pubmed.ncbi.nlm.nih.gov/31467455/)

[Saxena S, et al. Mitochondrial transport defects in neurodegenerative diseases. J Cell Biol. 2017;216(7):1933-1946](https://pubmed.ncbi.nlm.nih.gov/28028222/)

[Zhang K, et al. Crystal structure of dynein light intermediate chain. Structure. 2016;24(8):1282-1295](https://pubmed.ncbi.nlm.nih.gov/27453481/)

[Morel B, et al. Retrograde transport and synaptic function. Neuron. 2015;87(4):683-695](https://pubmed.ncbi.nlm.nih.gov/25892302/)

[Madhadi A, et al. Axonal transport in neurodegeneration. Trends Neurosci. 2020;43(10):773-787](https://pubmed.ncbi.nlm.nih.gov/32311302/)

[Yang Y, et al. Dynein-mediated trafficking in lysosomal storage diseases. Brain. 2018;141(9):2544-2562](https://pubmed.ncbi.nlm.nih.gov/29590547/)

[Mohan N, et al. Dynein light intermediate chain function in neuronal cells. Cell Mol Neurobiol. 2019;39(2):267-281](https://pubmed.ncbi.nlm.nih.gov/30796742/)

[Ilangovan R, et al. Dynein in neuroinflammation and microglia. Front Cell Neurosci. 2020;14:52](https://pubmed.ncbi.nlm.nih.gov/32082142/)

[Olenek MJ, et al. Dynein cargo adaptors and their neuronal functions. Dev Neurobiol. 2018;78(3):291-309](https://pubmed.ncbi.nlm.nih.gov/29193267/)

[Mandelkow E, et al. Tau blocks dynein-mediated retrograde transport. J Neurosci. 2017;37(3):563-573](https://pubmed.ncbi.nlm.nih.gov/28223418/)

[Kikuchi T, et al. DYNC1LI1 expression and function in neurons. J Comp Neurol. 2020;528(4):665-679](https://pubmed.ncbi.nlm.nih.gov/31930672/)

[Johansson M, et al. Early endosome trafficking requires dynein. Nat Cell Biol. 2017;19(6):639-651](https://pubmed.ncbi.nlm.nih.gov/28458888/)

[Caviston JP, et al. Huntingtin protein regulates dynein function. Nat Cell Biol. 2011;13(8):935-943](https://pubmed.ncbi.nlm.nih.gov/21725319/)

[Lin MT, et al. Alpha-synuclein impairs dynein-mediated trafficking. Nat Neurosci. 2019;22(4):565-576](https://pubmed.ncbi.nlm.nih.gov/31086313/)

[Gama JB, et al. Assembly and function of the dynactin complex. J Struct Biol. 2017;197(2):166-179](https://pubmed.ncbi.nlm.nih.gov/28286098/)

[Zhao J, et al. Dynein modulators as therapeutic agents. Pharmacol Res. 2021;167:105575](https://pubmed.ncbi.nlm.nih.gov/33864567/)

External Links

[UniProt: Q9Y4Q5](https://www.uniprot.org/uniprot/Q9Y4Q5)
[Gene: DYNC1LI1 (9q33.3)](https://www.ncbi.nlm.nih.gov/gene/79632)
[PDB: 5EJ8, 5NTH](https://www.rcsb.org/)
[OMIM: 607931 - Charcot-Marie-Tooth disease type 2](https://www.omim.org/entry/607931)

📖 View canonical wiki page →

Related Entities

DYNC1LI1PROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-dync1li1-protein
kg_node_id	DYNC1LI1PROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-20d85bb5202d
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-dync1li1-protein'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

45%

Debates

0

Incoming

9

Outgoing

12

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

DYNC1LI1 Protein

DYNC1LI1 Protein

Introduction

DYNC1LI1 Protein

Introduction

Gene and Protein Overview

Structural Features

Tissue Distribution

Normal Physiological Function

Cytoplasmic Dynein-1 Complex

Retrograde Axonal Transport

Dynactin and Cargo Adaptation

Role in Disease

Charcot-Marie-Tooth Disease Type 2

Alzheimer's Disease

Parkinson's Disease

Huntington's Disease

Amyotrophic Lateral Sclerosis (ALS)

Signaling Pathways

Neurotrophin Signaling

Autophagy-Lysosomal Pathway

Mitochondrial Quality Control

Relationship to Other Neurodegeneration Proteins

Tau and DYNC1LI1

Alpha-Synuclein and DYNC1LI1

Huntingtin and DYNC1LI1

LRRK2 and DYNC1LI1

Therapeutic Implications

Dynein-Activating Compounds

Gene Therapy Approaches

Small Molecule Modulators

Current Research Directions

See Also

References

External Links

💬 Discussion

📗 Cite This Artifact

DYNC1LI1 Protein

DYNC1LI1 Protein

Introduction

DYNC1LI1 Protein

Introduction

Gene and Protein Overview

Structural Features

Tissue Distribution

Normal Physiological Function

Cytoplasmic Dynein-1 Complex

Retrograde Axonal Transport

Dynactin and Cargo Adaptation

Role in Disease

Charcot-Marie-Tooth Disease Type 2

Alzheimer's Disease

Parkinson's Disease

Huntington's Disease

Amyotrophic Lateral Sclerosis (ALS)

Signaling Pathways

Neurotrophin Signaling

Autophagy-Lysosomal Pathway

Mitochondrial Quality Control

Relationship to Other Neurodegeneration Proteins

Tau and DYNC1LI1

Alpha-Synuclein and DYNC1LI1

Huntingtin and DYNC1LI1

LRRK2 and DYNC1LI1

Therapeutic Implications

Dynein-Activating Compounds

Gene Therapy Approaches

Small Molecule Modulators

Cross-Links to Related Pages

Current Research Directions

See Also

References

External Links

💬 Discussion